IP Library Granted Patent US 10,206,783
Granted Patent B2
US 10,206,783 · App. 14/964,621 · Granted Feb 19, 2019

Prosthetic device for human body and production method therefor

Inventor: Augusto Magagnoli (Bologna, IT)
Assignee: Cossington Limited
A61F2/30771A61F2/30942A61F2/34A61F2/3662A61F2/389A61F2/3859A61F2/4059A61F2002/3068A61F2002/3069A61F2002/3092A61F2002/30677A61F2002/30784A61F2002/30822A61F2002/30827A61F2002/4631A61F2310/00353
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,206,783
App. No.
14/964,621
Granted
Feb 19, 2019
Kind
B2
Abstract

A prosthetic device, adapted to be implanted in the human body and adapted to prevent and/or treat an infection that can arise and/or which has arisen at a bone site or at an articular site, wherein the prosthetic device has a prosthetic body provided with at least one surface for coupling, during use, with the bone or articular site and with at least one cavity placed along the coupling surface, wherein the at least one cavity is adapted to include, contain or house at least one pharmaceutical or medical substance.

Claims (24)

1. A prosthetic device, implantable in a bone or articular site of a human body, comprising:

a prosthetic body, said prosthetic body comprising at least one coupling surface adapted to come into contact during use with said bone or articular site,

wherein said at least one coupling surface comprises at least one cavity containing a filler material comprising at least one pharmaceutical or medical substance, said filler material being solid or in a solidifiable fluid form and having the at least one pharmaceutical or medical substance contained therein that prevents or treats infections, said filler material further having pores or channels dimensioned to prevent bone growth within the filler material,

wherein said filler material occupies an entire space defined by said at least one cavity, thereby completely filling said at least one cavity, and

wherein said filler material is flush with, or projecting from, said at least one coupling surface.

2. The prosthetic device according to claim 1 , wherein said at least one coupling surface of said prosthetic body comprises a plurality of cavities adjacent to each other, in a manner so as to define an open-cell structure along said coupling surface.

3. The prosthetic device according to claim 2 , wherein said open cells or cavities are separated from each other by ribs and/or have a perimeter formed by at least one rib.

4. The prosthetic device according to claim 3 , wherein said ribs comprise walls interposed between said open cells or cavities, projecting upward in a substantially perpendicular manner from an internal wall of said open cells or cavities.

5. The prosthetic device according to claim 1 , wherein said prosthetic body is made of a biologically-compatible material.

6. The prosthetic device according to claim 5 , wherein said biologically-compatible material comprises or is at least partially covered with acrylic resin, plastic material, ceramic material, resin with high porosity, bone cement or polymethylmethacrylate (PMMA), thermoplastic polymers, polyethylene, polypropylene, polyester, thermoforming polymers, metal oxides and/or nitrides, such as titanium nitride or a combination thereof or porous ceramic, plastic materials, or a material having a hard consistency.

7. The prosthetic device according to claim 1 , wherein said filler material comprises an acrylic resin, a composite material comprising calcium phosphate or an inorganic salt, calcium sulphate, bioglass, polyvinyl alcohol, a mixture thereof, or an absorbent material.

8. A prosthetic device, implantable in a bone or articular site of a human body, comprising:

a prosthetic body, said prosthetic body comprising at least one coupling surface adapted to come into contact during use with said bone or articular site,

wherein said at least one coupling surface comprises at least one cavity containing a filler material comprising at least one pharmaceutical or medical substance that prevents or treats infections, said filler material being solid or in a solidifiable fluid form and having the at least one pharmaceutical or medical substance contained therein, said filler material further having pores or channels dimensioned to prevent bone growth within the filler material, and

wherein said at least one coupling surface comprises at least one covering of the filler material placed at, or in contact with, an entirety of the at least one coupling surface, thereby being in contact with tissue of the bone or articular site.

9. The prosthetic device according to claim 1 , wherein said pores or channels gave an average size in cross section of about 100 micron.

10. The prosthetic device according to claim 1 , wherein said filler material is made of a same material as the prosthetic body.

11. The prosthetic device according to claim 8 , wherein said pores or channels gave an average size in cross section of about 100 micron.

12. The prosthetic device according to claim 8 , wherein said filler material is made of a same material as the prosthetic body.

13. A prosthetic device, implantable in a bone or articular site of a human body, comprising:

a prosthetic body, said prosthetic body comprising at least one coupling surface adapted to come into contact during use with said bone or articular site, and

a filler material comprising at least one pharmaceutical or medical substance that prevents or treats infections, said filler material being solid or in a solidifiable fluid form and having the at least one pharmaceutical or medical substance contained therein, said filler material further having pores or channels dimensioned to prevent bone growth within the filler material,

wherein said at least one coupling surface comprises at least one covering of the filler material comprising the at least one pharmaceutical or medical substance, and

wherein said filler material is flush with said at least one coupling surface.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2024
From: COSSINGTON LIMITED
To: TECRES S.P.A.
Reel/Frame 067739/0189 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2018
From: MAGAGNOLI, AUGUSTO
To: COSSINGTON LIMITED
Reel/Frame 047000/0630 →
Continuity (1)
Related Publication 20170165076A1 · Jun 15, 2017